Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Akobo Minerals receives more assay results

OSLO, 19 April 2022: Akobo Minerals (Euronext Oslo – “AKOBO”), the Scandinavian-based Ethiopian gold exploration and boutique mining company, today announced that it has released a new set of infill drilling assays from its Segele mine development project. The results are intended to allow for an upgrade of the resource classifications in the ongoing resource estimate.   · New infill drilling results including: · 136.5 g/t over 2.3m, including 580g/t over 0.5m · 114.7g/t over 13.1m, including 686g/t over 2.0m · 53.6g/t over 5.2m, including 446g/t over 0.4m · 46.

Hansa Biopharma announces U.S. FDA acceptance of Investigational New Drug (IND) application for Phase 3 study of imlifidase in anti-GBM disease

· Pivotal Phase 3 study to commence in 2022 and is expected to enroll 50 patients across the U.S. and Europe · Scientific advice on protocol obtained from both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) with the aim of conducting a global study · Clinical Phase 2 data suggests that deactivation of autoantibodies by imlifidase could alter the course of this serious autoimmune disease Lund, Sweden, April 19, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, today announces

Ilya Pharma makes strategic investment in bioanalytical company Nordic Bioanalysis to strengthen supply chain

Located at the previous Astra Zeneca site in Södertälje, south of Stockholm, Nordic Bioanalysis is GMP and ISO/IEC 17025 certified for microbial and chemical routine- and product specific analyses, stability studies and clinical storage Uppsala, April 19, 2022: Ilya Pharma (the Company), a clinical stage immunotherapy company announced that it has made a strategic investment in its supply chain to facilitate development of its ILP pipeline of skin and mucosal immunotherapy drug candidates by acquiring one of its long-term partners, Nordic Bioanalysis. Founded in 2010, Nordic Bioanalysis

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release April 19, 2022 at 12:20 p.m. Nokian Tyres has received an announcement from Amundi Asset Management on April 19, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement Amundi Asset Management’s and its funds combined direct and indirect holding in Nokian Tyres shares fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on April 14, 2022. The direct shareholding of Amundi Asset Management and its funds in Nokian Tyres amounted to 1,

BioStock: Idogen’s study approved in Norway and Sweden

Idogen has received the go-ahead from both the Swedish and Norwegian Medical Products Agencies to initiate a clinical phase I/IIa study with the cell therapy IDO 8 in hemophilia A. The study’s primary purpose is to show that the treatment is safe and to obtain preliminary data on the potential treatment effect.Read the full article at biostock.se: https://www.biostock.se/en/2022/04/idogens-study-approved-in-norway-and-sweden/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

EG7 intends to sell its subsidiary Innova at a price of EUR 32 million through a management buy-out - Relocates Toadman Interactive

INSIDE INFORMATION: STOCKHOLM, SWEDEN (APRIL 19, 2022) -- Enad Global 7 AB (publ) (“EG7” or the “Company”) has today entered into a letter of intent for the sale of the Company's subsidiary Innova Intellectual Properties S.à r.L. ("Innova") and to relocate Toadman Interactive studio from Russia. The sale of Innova is intended to be structured as a management buy-out (MBO) and the purchase price has been set at EUR 32 million. Structuring the Innova sale as an MBO is aimed to ensure the continuance of its ongoing business operations under the strong leadership of the existing management team

Webcast with Teleconference, Q1 / 2022

Nitro Games to host a Webcast with Teleconference on Monday 25 April 2022 09:30 Swedish time.Nitro Games Oyj Interim Report for January - March 2022 will be released on Monday 25 April 2022. The Company will do a presentation after the release of the report. Participants can join this presentation by a Webcast or Teleconference. Participants can send questions to the presenters via email below. 25 April 2022 09:30 (Europe/Stockholm) Details of event: https://financialhearings.com/event/43546 Language: English Activity: Webcast with Teleconference Webcast: https://tv.

Resolutions passed by the Annual General Meeting of Tecnotree Corporation and organization of the Board of Directors 0f Tecnotree Corporation

Tecnotree Corporation Stock Exchange Release 19 April 2022 at 12.00 EETThe Annual General Meeting of Tecnotree Corporation was held today 19 April 2022 at the company’s headquarters at Tekniikantie 14, 02150 Espoo. In order to prevent the spread of the COVID-19 pandemic, the Annual General Meeting was held without shareholders' and their proxy representatives' presence at the meeting venue. The Annual General Meeting confirmed the 2021 annual accounts and consolidated annual accounts and discharged the Board of Directors and the CEO from liability for the financial year 2021. The Annual

Registration of Etteplan Oyj’s new shares with the trade register and into book-entry system

ETTEPLAN OYJ, Stock Exchange Release April 19, 2022, at 12.00 EEST  Registration of Etteplan Oyj’s new shares with the trade register and into book-entry system   Etteplan Oyj’s 117,485 new shares subscribed in the directed share issue have been registered with the Trade Register on April 19, 2022 and will be entered into the book-entry system kept by Euroclear Finland Ltd without delay, at the latest on May 2, 2022. The Directed Share Issue is related to the acquisition of Syncore Technologies Ab. The Stock Exchange Release concerning the acquisition and the key terms and

FlexQube receives order worth $390 000

FlexQube has received a follow up order worth $390 000 from an existing customer in North America. The delivery will take place towards the end of 2022 to one of the customers manufacturing locations in Mexico. About FlexQube FlexQube is a technology company headquartered in Gothenburg, Sweden with subsidiaries in USA, Mexico, Germany and England. FlexQube offers solutions for cart-based material handling using a patented modular concept. FlexQube develops and designs customized solutions for both robotic and mechanical cart logistics. Through the own developed and unique automation

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release April 19, 2022 at 11:20 a.m. Nokian Tyres has received an announcement from Amundi Asset Management on April 14, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement Amundi Asset Management’s and its funds combined direct and indirect holding in Nokian Tyres shares exceeded the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on April 13, 2022. The direct shareholding of Amundi Asset Management and its funds in Nokian Tyres amounted to 1,

Frontiers in Immunology publishes article about ABNCoV2

Hørsholm, Denmark, April 19, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that Frontiers in Immunology published an article about the high level of antibodies induced by the ABNCoV2 COVID-19 vaccine in non-human primates.Excerpt: “In summary, ABNCoV2 induced strong and long-lasting neutralizing antibody responses and efficacy against SARS-CoV-2 in NHP (non-human primates). Together with the comparable variant neutralization capacity seen in the serum of vaccinated animals, these data may indicate a potential for broad protection

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 97 - 19 APRIL 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 56/2022. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

SimCorp A/S – Share buyback program

Company Announcement no. 16/2022On February 15, 2022 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 15, 2022 to July 31, 2022. The following transactions have been executed under the program:          Date                 Number of shares

Valmet to deliver a wash press to Nippon Paper Industries Co. Ltd. Akita mill in Japan

Valmet Oyj’s trade press release on April 19, 2022 at 11:00 a.m. EETValmet will deliver a TwinRoll™ Evolution wash press  and a screw conveyor to Nippon Paper Industries Co. Ltd. Akita mill. The start-up is scheduled for end of May 2023. The order is included in Valmet’s orders received of the first quarter 2022. The value of the order will not be disclosed. “Our group is making efforts to reduce greenhouse gas (GHG) emissions and environmental impact in order to achieve a business model aimed at carbon neutrality.

Capital increase in TORM due to exercise of Restricted Share Units as part of TORM’s incentive program

TORM plc (“TORM”) increases its share capital by 7,089 A-shares (corresponding to a nominal value of USD 70.89) as a result of the exercise of a corresponding number of Restricted Share Units.   The capital increase is carried out without any pre-emption rights for existing shareholders or others. All the 7,089 new shares have been subscribed for in cash at DKK 43.4 per A-share. All with a nominal value of USD 0.01 each.   The new shares are ordinary shares without any special rights and are negotiable instruments. The new shares give right to dividends and other rights in

Fellow Bank appoints Kukka Lehtimäki as CFO and expands its management team

FELLOW BANK PLC STOCK EXCHANGE RELEASE 19.4.2022 AT 10:30 AM EETKukka Lehtimäki (M.Sc. (Econ.&Bus.Adm.)) has been appointed Fellow Bank Plc's CFO and member of the Management Team. She will start in this position on 2.5.2022. Kukka Lehtimäki will join Fellow Bank from OP Financial Group's financial management. In the past, she has worked e.g. as the auditor of financial companies at KPMG. Fellow Bank also expands its Management Team by appointing Riikka Järvinen(M.Sc. (Econ.&Bus.Adm.)), Marketing Director, as a member of the Management Team as of 19 April 2022. Riikka Järvinen started

Visma steps up innovation with a new tech centre in Porto

Visma is establishing a new technology centre in Porto this spring. The launch reinforces the company’s leadership in innovation and commitment to creating technology for a resilient society. The tech centre will employ around 50 people during its first year and reach 200 employees by 2025. The Visma Group consists of over 14,000 people across Europe and Latin America, of which 6,500 are developers. The new tech centre will strengthen its already extensive tech community, making it one of the largest in Europe. It will serve as one of Visma’s main competence hubs, focusing on advancing

BioStock Investor Pitch: ExpreS2ion Biotechnologies

BioStock invites you to watch ExpreS2ion Biotechnologies' company presentation today at 10:00. The company develops protein-based vaccines using its platform technology ExpreS2. Today, the pipeline consists of projects in four indications: covid-19, breast cancer, influenza and malaria. The company is currently carrying out a rights issue of 73 million SEK to finance the completion of preclinical studies within the breast cancer project ES2B-C001, as well as to further develop the pipeline and strengthen its platform technology. CEO Bent U. Frandsen tells us more about ExpreS2ion's vision in

Bulten completes divestment of Russian operation

Bulten has today signed an agreement to divest its Russian operation to the Russian company CAR SEATS LLC, and to redeem the Russian automotive manufacturer GAZ’s shares in the joint venture that Bulten and GAZ have owned since 2012.“I am pleased that in a short time we have been able to reach a solution. For us this means that we can now focus fully on long-term sustainable markets,” says Anders Nyström, President and CEO of Bulten.  The purchase price corresponds to approximately SEK 10 million. The financial net effect on Bulten’s profit and loss amounts to a preliminary SEK -85

Invitation to webcast for the presentation of Lime Technologies’ Interim Report, January - March 2022

Lime Technologies’ Interim Report for January - March 2022, will be published on Tuesday April 26, 2022, at 07:50 CET.The same day, at 09:30 CET; analysts, investors, media and other interested parties are invited to attend a webcast where Lime’s CEO, Nils Olsson, and CFO/Head of Investor Relations, Magnus Hansson, will comment on the published report and answer questions. The presentation will be held in English. The presentation material will be available on Lime’s website  after the webcast. How

Finnair flies to 77 destinations in winter 2022, as travel continues to recover

Finnair has updated its offering for winter 2022-2023, with a view to the Russian airspace closure. Finnair flies to ten Asian destinations, five US destinations, and 62 European destinations from its Helsinki hub during the winter. Finnair also has direct flights to the US and Thailand from Stockholm Arlanda.   “We are happy to see travel recovering at a rapid pace, and our winter network caters to the needs of both corporate and leisure travelers,” says Ole Orvér, Chief Commercial Officer, Finnair.   Finnair’s US offering comprises daily flights to New York John F Kennedy airport

The first subjects dosed successfully with no adverse events in the phase I trial of BSG005

April 19, 2022: Biosergen AB (“Biosergen” or the “Company”) today announced that there were no adverse events at all reported after the first volunteers have been dosed with the Company’s proprietary antifungal drug candidate BSG005.The Company has received the first safety review group outcome of the safety and laboratory data following this first administration of BSG005 in the phase I study in Australia. The review of the data revealed that there were no adverse events reported at all and all laboratory data were OK. This is very positive news and also promising for the next dose

Polymer Factory collaborate with University of Massachusetts Amherst

Polymer Factory Sweden AB (publ) has signed a material transfer agreement with the University of Massachusetts Amherst (UMass) for transfer of materials from its BowtieD® platform.Polymer Factory has signed a material transfer agreement with UMass for research incorporating products from Polymer Factory’s BowtieD® platform. The research focus is within oncology and immunotherapy. CTO Michael Malkoch comments: “With this agreement secured, renowned researchers from UMass will now have the opportunity to explore Polymer Factory’s dendrimer nanocarrier platform as the most sophisticated

There are no items matching the current filter
There are no more items matching the current filter
Back to top